Editorial: a non‐dietary treatment for coeliac disease—two steps forward, one step back? Authors’ reply

Michael Bodd, Melinda Ráki, Elin Bergseng, Jørgen Jahnsen, Knut E. A. Lundin, Ludvig M. Sollid, Direct cloning and tetramer staining to measure the frequency of intestinal gluten‐reactive T cells in celiac disease European Journal of Immunology. ,vol. 43, pp. 2605- 2612 ,(2013) , 10.1002/EJI.201343382

J. A. Tye-Din, J. A. Stewart, J. A. Dromey, T. Beissbarth, D. A. van Heel, A. Tatham, K. Henderson, S. I. Mannering, C. Gianfrani, D. P. Jewell, A. V. S. Hill, J. McCluskey, J. Rossjohn, R. P. Anderson, Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease Science Translational Medicine. ,vol. 2, pp. 1- 14 ,(2010) , 10.1126/SCITRANSLMED.3001012

Donald D. Kasarda, Can an Increase in Celiac Disease Be Attributed to an Increase in the Gluten Content of Wheat as a Consequence of Wheat Breeding Journal of Agricultural and Food Chemistry. ,vol. 61, pp. 1155- 1159 ,(2013) , 10.1021/JF305122S

Gautam Goel, Tim King, A James Daveson, Jane M Andrews, Janakan Krishnarajah, Richard Krause, Gregor JE Brown, Ronald Fogel, Charles F Barish, Roger Epstein, Timothy P Kinney, Philip B Miner, Jason A Tye-Din, Adam Girardin, Juha Taavela, Alina Popp, John Sidney, Markku Mäki, Kaela E Goldstein, Patrick H Griffin, Suyue Wang, John L Dzuris, Leslie J Williams, Alessandro Sette, Ramnik J Xavier, Ludvig M Sollid, Bana Jabri, Robert P Anderson, None, Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies The Lancet Gastroenterology & Hepatology. ,vol. 2, pp. 479- 493 ,(2017) , 10.1016/S2468-1253(17)30110-3

Jonas F Ludvigsson, Carolina Ciacci, Peter HR Green, Katri Kaukinen, Ilma R Korponay-Szabo, Kalle Kurppa, Joseph A Murray, Knut Erik Aslaksen Lundin, Markku J Maki, Alina Popp, Norelle R Reilly, Alfonso Rodriguez-Herrera, David S Sanders, Detlef Schuppan, Sarah Sleet, Juha Taavela, Kristin Voorhees, Marjorie M Walker, Daniel A Leffler, Outcome measures in coeliac disease trials : the Tampere recommendations Gut. ,vol. 67, pp. 1410- 1424 ,(2018) , 10.1136/GUTJNL-2017-314853

Jack A Syage, Ciarán P Kelly, Matthew A Dickason, Angel Cebolla Ramirez, Francisco Leon, Remedios Dominguez, Jennifer A Sealey-Voyksner, Determination of gluten consumption in celiac disease patients on a gluten-free diet The American Journal of Clinical Nutrition. ,vol. 107, pp. 201- 207 ,(2018) , 10.1093/AJCN/NQX049

Gautam Goel, Jason A. Tye-Din, Shuo-Wang Qiao, Amy K Russell, Toufic Mayassi, Cezary Ciszewski, Vikas K Sarna, Suyue Wang, Kaela E Goldstein, John L Dzuris, Leslie J Williams, Ramnik J Xavier, Knut EA Lundin, Bana Jabri, Ludvig M Sollid, Robert P. Anderson, None, Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease Science Advances. ,vol. 5, ,(2019) , 10.1126/SCIADV.AAW7756

Kenneth E Truitt, A James M Daveson, Hooi C Ee, Gautam Goel, James MacDougall, Kristin Neff, Robert P. Anderson, None, Randomised clinical trial: a placebo‐controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease Alimentary Pharmacology & Therapeutics. ,vol. 50, pp. 547- 555 ,(2019) , 10.1111/APT.15435

Jason A Tye‐Din, A James M Daveson, Hooi C Ee, Gautam Goel, James MacDougall, Sarah Acaster, Kaela E Goldstein, John L Dzuris, Kristin M Neff, Kenneth E Truitt, Robert P. Anderson, None, Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Alimentary Pharmacology & Therapeutics. ,vol. 50, pp. 901- 910 ,(2019) , 10.1111/APT.15477

Hannah Mitchell, Mayur Garg, Editorial: a non-dietary treatment for coeliac disease-two steps forward, one step back? Alimentary Pharmacology & Therapeutics. ,vol. 50, pp. 955- 956 ,(2019) , 10.1111/APT.15470